Most adults should continue to pay nothing
out-of-pocket for COVID-19 vaccines. Uninsured/underinsured adults can receive vaccine at no cost at participating Bridge Access Program locations. Visit vaccines.gov to find a Bridge Access Program location.
This independent, nonprofit organization provides assistance to qualifying patients with financial hardship who generally have no prescription insurance.
Provides access and reimbursement support to patients taking BAVENCIO® (avelumab) injection in the United States.
CoverOne™ is brought to you by EMD Serono Inc. and Pfizer Inc.
Assists eligible patients with their co-pay costs.
*Terms and conditions apply. In some cases, patients may be only eligible for this co-pay or savings card if their prescription plan covers the Pfizer medicine they’ve been prescribed.
Offers comprehensive reimbursement support services and Copay assistance for patients treated with Pfizer Biosimilars.
Please contact the program directly for more information.
Helps patients understand their insurance for EUCRISA® (crisaborole) ointment, 2%, and also helps eligible patients save on their medicine.
*Patients must be at or below 400% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Helps patients understand their insurance for LITFULOTM (ritlecitinib) and also helps eligible patients save on their medicine.
Call 1-833-956-DERM (3376) or Visit Site
An online wholesaler that offers brand-name and generic medicines at significantly reduced prices.
Call 1-855-440-6852 or Visit Site
The Myfembree® Support Program is designed to help your patients throughout their treatment journey. We offer financial assistance options, dedicated support staff, and other helpful resources once patients have been prescribed Myfembree®.
In this resource, the various components of the program will be described in detail to ensure that patients understand which offerings, if any, they are eligible for.
Call 1-833-MYFEMBREE (1-833-693-3627)
The Nurtec® Support Program is designed to help your patients throughout their treatment journey. We offer financial assistance options, dedicated support staff, and other helpful resources once patients have been prescribed Nurtec®.
In this resource, the various components of the program will be described in detail to ensure that patients understand which offerings, if any, they are eligible for.
Call 1-833-4NURTEC (1-833-468-7832)
The Oxbryta® Support Program is designed to help your patients throughout their treatment journey. We offer financial assistance options, dedicated support staff, and other helpful resources once patients have been prescribed Oxbryta®.
In this resource, the various components of the program will be described in detail to ensure that patients understand which offerings, if any, they are eligible for.
Call 1-833-428-4968
Helps eligible patients access SOMAVERT® (pegvisomant) for injection.
*Patients must be at or below 500% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Helps eligible patients access GENOTROPIN® (somatropin) for injection
*Patients must be at or below 500% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Offers comprehensive reimbursement and patient support services for patients treated with Pfizer Biosimilars.
*Patients must be at or below 500% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Provides patients who have been prescribed BeneFIX® Coagulation Factor IX (Recombinant), or XYNTHA® Antihemophilic Factor (Recombinant) with access to relevant Pfizer tools and programs based on their individual needs.
*Patients must be at or below 500% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
Provides patients with financial assistance and personalized support for their Pfizer oncology medicines:
AROMASIN® (exemestane) tablets, BESPONSA™ (inotuzumab ozogamicin), BOSULIF® (bosutinib) tablets, BRAFTOVI® (encorafenib) capsules, CAMPTOSAR® (irinotecan hydrochloride) injection, DAURISMO™ (glasdegib) tablets, ELLENCE® (epirubicin hydrochloride) injection, EMCYT® (estramustine phosphate sodium) capsules, IBRANCE® (palbociclib) capsules, IDAMYCIN PFS® (idarubicin hydrochloride) injection, INLYTA® (axitinib) tablets, LORBRENA® (lorlatinib) tablets, MEKTOVI® (binimetinib) tablets, MYLOTARG™ (gemtuzumab ozogamicin) for injection, NIVESTYM® (filgrastim-aafi) injection, NYVEPRIA™ (pegfilgrastim-apgf) injection, RETACRIT® (epoetin alfa-epbx) injection, RUXIENCE™ (rituximab-pvvr) injection, SUTENT® (sunitinib malate) capsules, TALZENNA® (talazoparib) capsules, TORISEL® (temsirolimus) injection, TRAZIMERA™ (trastuzumab-qyyp) for injection, VIZIMPRO® (dacomitinib) tablets, XALKORI® (crizotinib) capsules, and ZIRABEV™ (bevacizumab-bvzr) injection
Helps verify patients' insurance benefits and their understanding of coverage requirements for Comirnaty® (COVID-19 Vaccine, mRNA)
To receive assistance with your Pfizer vaccines, please have your Prescriber call us directly at 1-866-706-2400.
Helps verify patients’ insurance benefits and their understanding of coverage requirements for PREVNAR 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), TRUMENBA® (Meningococcal Group B Vaccine) and Prevnar 20™ (Pneumococcal 20-valent Conjugate Vaccine).
Assists eligible patients with their co-pay costs.
Terms and conditions apply. In some cases, patients may be only eligible for this co-pay or savings card if their prescription plan covers the Pfizer medicine they've been prescribed.
Call 1-855-440-6852 or Visit Site
Pfizer IGuide Phone: 1-844-448-4337, Fax: 1-844-868-6329, Hours: Monday-Friday (excluding holidays) 8 am to 8 pm ET.
Helps eligible patients who have been prescribed VYNDAQEL® (tafamidis meglumine) or VYNDAMAX™ (tafamidis) understand their insurance coverage, research financial assistance resources, and identify third-party resources that may be available.
*Patients must be at or below 500% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
XELSOURCESM
Provides assistance to eligible patients who have been prescribed XELJANZ® (tofacitinib) tablets/XELJANZ® XR (tofacitinib) extended-release tablets.
*Patients must be at or below 500% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
YourSource is a free patient support program dedicated to helping eligible patients start and continue Oxbryta® as prescribed by their healthcare professional.
Call 1-833-428-4968 or Visit YourSourceSupport.com
The Zavzpret™ OneSource Program is designed to help your patients throughout their treatment journey. We offer financial assistance options, dedicated support staff, and other helpful resources once patients have been prescribed Zavzpret™.
In this resource, the various components of the program will be described in detail to ensure that patients understand which offerings, if any, they are eligible for.
Call 1-877-ZAVZPRET (1-877-928-9773)
Provides financial assistance to eligible patients who have been prescribed oral ZYVOX® (linezolid).
*Patients must be at or below 400% of the Federal Poverty Level, adjusted for family size, to qualify for free medicine through the Pfizer Patient Assistance Program. Additional program eligibility applies. Please contact the program directly for more information.
